Dáil Éireann Debate, Thursday - 14 December 2017
405. Deputy Billy Kelleher asked the Minister for Health the number of medicines that have had their price reduced as of 1 December 2017 further to the framework agreement on the supply and pricing of medicines; the details of each medicine; and the extent of the price cut. [53856/17]
Amharc ar fhreagraThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013.
The four-year Framework Agreement on the Supply and Pricing of Medicines (IPHA Agreement), signed in July 2016, provides for an annual price realignment, which will ensure that the prices of medicines in Ireland reduce in line with price reductions across the reference countries. The details of this realignment is published by the HSE's Corporate Pharmaceutical unit on their website, the details of which can be found at the following link: https://www.hse.ie/eng/about/Who/cpu/IPHA-Price-Reduction-2017/.
